COM:PRECISIONBIOSCIENCES
Precision BioSciences, Inc.
- Stock
Last Close
6.50
22/11 21:00
Market Cap
55.69M
Beta: -
Volume Today
105.61K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 4.75M - | 7.63M 60.67% | 11.60M 52.02% | 12.49M 7.72% | 3.78M 69.78% | |||
average payables | 2.01M - | 2.13M 5.74% | 1.41M 33.51% | 968K 31.57% | 1.18M 22.37% | 2.10M 76.99% | ||
average receivables | 524.50K - | 996K 89.90% | 5.48M 450.45% | 5.24M 4.35% | 604K 88.48% | 810.50K 34.19% | ||
book value per share | -0.78 - | 0.82 204.02% | 3.29 304.15% | 0.85 74.08% | 1.55 81.94% | 0.69 55.74% | 0.00 99.29% | |
capex per share | -0.17 - | -0.32 93.37% | -0.59 83.70% | -0.10 83.54% | -0.10 2.26% | -0.04 61.81% | -0.00 98.65% | |
capex to depreciation | -3.88 - | -6.66 71.74% | -4.64 30.35% | -0.51 88.95% | -0.57 11.00% | -0.37 35.23% | -0.24 35.69% | |
capex to operating cash flow | 0.23 - | 0.30 31.64% | 0.35 14.59% | 0.06 83.42% | 0.53 828.73% | 0.07 86.43% | 0.02 67.93% | |
capex to revenue | -0.86 - | -1.44 67.85% | -1.11 23.01% | -0.21 81.32% | -0.05 75.75% | -0.13 163.27% | -0.04 69.63% | |
cash per share | 1.87 - | 2.10 12.78% | 4.31 104.67% | 1.73 59.94% | 2.45 41.84% | 2.16 11.89% | 0.03 98.59% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 1.24 - | 34.44 2,681.26% | 15.84 54.02% | 150.30 848.92% | 1.54 98.97% | 10.47 579.15% | 6.75 35.54% | |
debt to assets | 0.02 - | 0.02 13.20% | 0.03 23.69% | 0.07 141.45% | 0.04 38.49% | 0.11 163.45% | 0.01 93.75% | |
debt to equity | -0.06 - | 0.08 242.45% | 0.05 39.35% | 0.24 379.86% | 0.10 57.78% | 0.45 347.56% | 0.06 86.57% | |
dividend yield | ||||||||
earnings yield | -0.04 - | -0.05 49.75% | -0.14 165.27% | -0.25 75.88% | -0.07 71.66% | -1.18 1,550.53% | -0.00 99.88% | |
enterprise value | 524.12M - | 751.89M 43.46% | 402.37M 46.49% | 354.67M 11.86% | 299.74M 15.49% | -57.94M 119.33% | 41.95B 72,497.77% | |
enterprise value over ebitda | -25.81 - | -16.50 36.07% | -4.60 72.10% | -3.58 22.36% | -10.40 190.95% | 0.59 105.66% | -986.38 167,738.29% | |
ev to operating cash flow | -21.69 - | -14.54 32.97% | -5.67 61.02% | -4.06 28.37% | -27.62 580.49% | 1.27 104.59% | -498.70 39,480.07% | |
ev to sales | 80.83 - | 69.09 14.53% | 18.09 73.81% | 14.60 19.29% | 2.59 82.23% | -2.31 188.98% | 860.87 37,390.19% | |
free cash flow per share | -0.88 - | -1.37 55.59% | -2.28 65.75% | -1.78 22.05% | -0.28 84.02% | -0.56 96.71% | -0.02 95.99% | |
free cash flow yield | -0.05 - | -0.08 55.59% | -0.16 108.12% | -0.21 29.82% | -0.04 81.99% | -0.47 1,123.25% | -0.00 99.56% | |
graham net net | -1.08 - | 0.11 110.08% | 2.13 1,861.81% | -0.11 105.01% | 0.55 617.45% | 0.18 66.72% | -0.01 103.34% | |
graham number | 3.32 - | 4.15 24.80% | 12.13 192.21% | 6.34 47.68% | 4.29 32.36% | 4.65 8.38% | 0.04 99.10% | |
income quality | 1.15 - | 1.12 1.91% | 0.76 31.94% | 0.80 4.85% | 0.35 55.76% | 0.41 15.56% | 1.37 234.70% | |
intangibles to total assets | 0.00 - | 0.01 754.19% | 0.01 42.45% | 0.01 50.20% | 0.01 5.90% | 0.01 41.55% | 0.00 55.77% | |
interest coverage | -479.14 - | -298.50 - | -90.34 69.74% | 19.07 121.11% | ||||
interest debt per share | 0.04 - | 0.07 48.17% | 0.17 151.66% | 0.20 21.15% | 0.16 22.08% | 0.32 103.28% | -0.00 100.09% | |
inventory turnover | ||||||||
invested capital | -0.06 - | 0.08 242.45% | 0.05 39.35% | 0.24 379.86% | 0.10 57.78% | 0.45 347.56% | 0.06 86.57% | |
market cap | 586.92M - | 855.09M 45.69% | 583.26M 31.79% | 433.94M 25.60% | 434.29M 0.08% | 104.60M 75.92% | 42.06B 40,113.86% | |
net current asset value | -34.72M - | 17.04M 149.06% | 96.75M 467.97% | -169K 100.17% | 41.42M 24,611.24% | 21.37M 48.41% | -4.56M 121.34% | |
net debt to ebitda | 3.09 - | 2.27 26.77% | 2.07 8.61% | 0.80 61.39% | 4.67 484.28% | 1.65 64.65% | 2.72 64.60% | |
net income per share | -0.63 - | -0.94 49.75% | -1.98 111.28% | -2.09 5.61% | -0.53 74.85% | -1.40 165.42% | -0.02 98.86% | |
operating cash flow per share | -0.72 - | -1.05 46.89% | -1.69 60.31% | -1.68 0.69% | -0.18 88.99% | -0.52 181.47% | -0.02 95.79% | |
payables turnover | ||||||||
receivables turnover | 294.73 - | 10.60 96.40% | 23.04 117.47% | 2.43 89.46% | 236.74 9,648.39% | 34.86 85.28% | 54.08 55.15% | |
research and ddevelopement to revenue | 3.13 - | 4.15 32.27% | 3.71 10.61% | 4.04 8.95% | 1.00 75.30% | 3.34 235.29% | 1.10 67.25% | |
return on tangible assets | -0.29 - | -0.34 15.49% | -0.36 6.13% | -0.73 105.63% | -0.15 79.85% | -0.52 251.58% | -0.38 25.87% | |
revenue per share | 0.19 - | 0.22 15.21% | 0.53 138.59% | 0.47 11.87% | 1.97 321.77% | 0.29 85.50% | 0.01 95.56% | |
roe | 0.80 - | -1.15 243.96% | -0.60 47.72% | -2.45 307.42% | -0.34 86.18% | -2.03 499.70% | -3.25 59.85% | |
roic | 0.85 - | -1.15 235.40% | -0.54 53.30% | -1.68 211.33% | -0.37 77.81% | -1.20 221.59% | -2.01 68.11% | |
sales general and administrative to revenue | 1.24 - | 1.26 1.62% | 1.22 3.27% | 1.48 22.15% | 0.34 76.86% | 1.65 381.56% | 0.80 51.52% | |
shareholders equity per share | -0.78 - | 0.82 204.02% | 3.29 304.15% | 0.85 74.08% | 1.55 81.94% | 0.69 55.74% | 0.00 99.29% | |
stock based compensation to revenue | 0.06 - | 0.23 248.80% | 0.40 78.36% | 0.57 41.21% | 0.14 74.82% | 0.76 435.10% | 0.29 62.33% | |
tangible asset value | -26.46M - | 38.49M 245.49% | 136.88M 255.59% | 43.05M 68.55% | 89.12M 107.01% | 59.09M 33.70% | 18.46M 68.76% | |
tangible book value per share | -0.79 - | 0.79 199.86% | 3.26 315.20% | 0.83 74.62% | 1.52 83.53% | 0.67 55.73% | 0.00 99.29% | |
working capital | 55.13M - | 101.60M 84.30% | 166.74M 64.11% | 62.73M 62.38% | 125.77M 100.48% | 139.44M 10.87% | 86.37M 38.06% |
All numbers in (except ratios and percentages)